Evidence on aspirin and cancer comes from two main sources: (1) the effect of aspirin upon biological mechanisms in cancer, and (2) clinical studies of patients with cancer, some of whom take aspirin. A series of systematic literature searches identified ...
Trial participants who took a low-dose aspirin daily were no more likely to be diagnosed with cancer than those who took a placebo. But they did have a moderately higher risk of being diagnosed with advanced cancer and were more likely to die from advanced cancer.
A federal advisory panel supports aspirin to reduce the risk of colorectal cancer, while researchers are investigating whether it may help reduce the risk of other cancers.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.